TIMENTIN IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Timentin In Plastic Container, and when can generic versions of Timentin In Plastic Container launch?
Timentin In Plastic Container is a drug marketed by Glaxosmithkline and is included in one NDA.
The generic ingredient in TIMENTIN IN PLASTIC CONTAINER is clavulanate potassium; ticarcillin disodium. There are twenty-seven drug master file entries for this compound. Additional details are available on the clavulanate potassium; ticarcillin disodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TIMENTIN IN PLASTIC CONTAINER?
- What are the global sales for TIMENTIN IN PLASTIC CONTAINER?
- What is Average Wholesale Price for TIMENTIN IN PLASTIC CONTAINER?
Summary for TIMENTIN IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 10 |
| Clinical Trials: | 1 |
| Patent Applications: | 162 |
| DailyMed Link: | TIMENTIN IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for TIMENTIN IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Osprey Medical, Inc | Phase 2 |
US Patents and Regulatory Information for TIMENTIN IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glaxosmithkline | TIMENTIN IN PLASTIC CONTAINER | clavulanate potassium; ticarcillin disodium | INJECTABLE;INJECTION | 050658-001 | Dec 15, 1989 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
